Delivery Order SPE2DB22D1002-SPE2DB24FKVA2
- Not listed
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies to the Defense Logistics Agency (DLA), a defense agency. The $32,921.95 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 8, 2024, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $1,283.04 and was issued on December 3, 2021, with a completion date of December 6, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of 4,565,877,751 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 19, 2024 with a ceiling value of $11,523.56. The delivery order contract is firm-fixed price and has an ultimate completion date of September 20, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA). The $5,218.24 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 20, 2025, with a completion date of March 21, 2025. The contract is a delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,812.19. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of September 26, 2023. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency. The $9,012.76 firm fixed price delivery order was awarded on June 20, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a performance period ending on June 23, 2025. The contract is not set aside and was awarded as a delivery order. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, has a ceiling value of $5,383.08 and an ultimate completion date of June 18, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of 4,564,983,504 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 24, 2024 as a Firm Fixed Price Delivery Order with a ceiling value of $7,177.49. The contract has an ultimate completion date of June 25, 2024 and is not designated with a set-aside requirement. AmerisourceBergen holds...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $1,495.30. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKVA2Delivery Order
This federal contract award is for the delivery of 4562991442 EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 5, 2023, with a ceiling value of $1,664.76 and a completion date of December 6, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/5/23 |